Nuwellis, Inc. NUWE
Set alert
At close · Oct 30
After hours · Oct 30, 7:58 PM ET
- YTD
- -90.67%
- 1 year
- -95.73%
- Open
- 5.59
- Prev close
- 5.78
- Mkt cap
- 2.30M
- Vol
- 311.40K
- Avg vol
- 897.87K
- EPS
- 3,923.28
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.20
- High
- 6.10
- Forward P/E
- -0.41
- Beta
- 0.36
- Short ratio
- 0.26
- Inst. own
- 1.46%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.53
- 200-d avg
- 5.15
- 1y target
- 16.00
3M chart
Events in this range
- Oct 27, 2026Split: 1 for 9
Signals (11)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 27, 2026 | 4 days ago |
| SMA: Bullish | Oct 27, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 27, 2026 | 4 days ago |
| RSI: Overbought | Oct 27, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| RSI: Oversold | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
Key statistics
- Market cap
- 4.64M
- Enterprise value
- 2.30M
- Trailing P/E
- 0.00
- Forward P/E
- -0.41
- PEG ratio
- 0.00
- Price / sales
- 0.51
- Price / book
- 0.06
- EPS (TTM)
- -60.77
- Beta
- 0.36
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -232.24%
- Revenue (TTM)
- 9.01M
- Revenue growth
- 5.70%
- Free cash flow
- -12.32M
- Total cash
- 1.02M
- Total debt
- 654.00K
- Return on equity
- -987.45%
- Shares outstanding
- 4.37M
- Short % of float
- 17.27%
- 50-day average
- 1.53
- 200-day average
- 5.15
Analyst view
Consensus: none
- Strong buy1
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | -0.88 | 1.74 | +2.62 | +297.73% |
| Aug 13, 2024 | Jun 1, 2024 | -9.49 | -18.85 | -9.36 | -98.63% |
| May 7, 2024 | Mar 1, 2024 | 0.00 | -20.98 | — | — |
| Mar 5, 2024 | Dec 1, 2023 | 0.00 | -78.32 | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | -63.29 | — | — |
| Aug 8, 2023 | Jun 1, 2023 | 0.00 | -127.62 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2024 | Roth MKM | reit | Buy | Buy |
| Jul 29, 2024 | Roth MKM | init | — | Buy |
| Nov 8, 2023 | Ladenburg Thalmann | down | Buy | Neutral |
About Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- nuwellis.com
News
Your note
Sign in to keep a note on NUWE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JARAMILLO NESTOR JR, | Chief Executive Officer | Purchase | Mar 14, 2023 | 4,098 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| HRT Financial LP | 0.35% | 15,127 | 16.03K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.31% | 13,631 | 14.45K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.15% | 6,346 | 6.73K | Sep 29, 2024 |
| Morgan Stanley | 0.01% | 312 | 330 | Sep 29, 2024 |
| JP Morgan Chase & Company | 0.00% | 1 | 1 | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 11 | 11 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.17% | 7,478 | 7.93K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 3,189 | 3.38K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 2,759 | 2.92K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.03% | 1,426 | 1.51K | Sep 29, 2024 |